Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease

被引:198
|
作者
Bogdanov, MB
Andreassen, OA
Dedeoglu, A
Ferrante, RJ
Beal, MF
机构
[1] Massachusetts Gen Hosp, Neurol Serv, Neurochem Lab, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Bedford, MA USA
[4] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
[6] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA
[7] New York Presbyterian Hosp, New York, NY USA
关键词
free radicals; Huntington's disease; 8-hydroxy-2-deoxyguanosine; oxidative damage; microdialysis; transgenic;
D O I
10.1046/j.1471-4159.2001.00689.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial dysfunction and oxidative damage may play a role in the pathogenesis of Huntington's disease (HD). We examined concentrations of 8-hydroxy-2-deoxyguanosine (OH(8)dG), a well-established marker of oxidative damage to DNA, in a transgenic mouse model of HD (R6/2). Increased concentrations of OH(8)dG were found in the urine, plasma and striatal microdialysates of the HD mice. Increased concentrations were also observed in isolated brain DNA at 12 and 14 weeks of age. Immunocytochemistry showed increased OH(8)dG staining in late stages of the illness. These results suggest that oxidative damage may play a role in the pathogenesis of neuronal degeneration in the R6/2 transgenic mouse model of HD.
引用
收藏
页码:1246 / 1249
页数:4
相关论文
共 50 条
  • [41] CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
    Chou, SY
    Lee, YC
    Chen, HM
    Chiang, MC
    Lai, HL
    Chang, HH
    Wu, YC
    Sun, CN
    Chien, CL
    Lin, YS
    Wang, SC
    Tung, YY
    Chang, C
    Chern, YJ
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) : 310 - 320
  • [42] Neuroprotective effects of kynurenic acid analog in a transgenic mouse model of Huntington's disease
    Klivenyi, P.
    Zadori, D.
    Fulop, F.
    Toldi, J.
    Vecsei, L.
    MOVEMENT DISORDERS, 2009, 24 : S166 - S166
  • [43] Direct Evidence of Progressive Cardiac Dysfunction in a Transgenic Mouse Model of Huntington's Disease
    Wood, Nigel I.
    Sawiak, Stephen J.
    Buonincontri, Guido
    Niu, Youguo
    Kane, Andrew D.
    Carpenter, T. Adrian
    Giussani, Dino A.
    Morton, A. Jennifer
    JOURNAL OF HUNTINGTONS DISEASE, 2012, 1 (01) : 57 - 64
  • [44] Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease
    Kong, Geraldine
    Kim-Anh Le Cao
    Judd, Louise M.
    Li, ShanShan
    Renoir, Thibault
    Hannan, Anthony J.
    NEUROBIOLOGY OF DISEASE, 2020, 135
  • [45] Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease
    Cuesta, Marc
    Aungier, Juliet
    Morton, A. Jennifer
    NEUROBIOLOGY OF DISEASE, 2014, 63 : 85 - 91
  • [46] EVALUATION OF PRIDOPIDINE IN THE TRANSGENIC YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Miralles, Marta Garcia
    Tan, Liang Juin
    Lim, Madeline
    Geva, Michal
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A92 - A92
  • [47] Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
    Zadori, Denes
    Geisz, Andrea
    Vamos, Eniko
    Vecsei, Laszlo
    Klivenyi, Peter
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 94 (01) : 148 - 153
  • [48] Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model
    Mohammed, Abuelnor
    Ramadan, Azza
    Elnour, Asim Ahmed
    Saeed, Ali Awadallah Ali Mohamed
    Al Mazrouei, Nadia
    Alsulami, Fahad T.
    Alqarni, Yousef Saeed
    Menon, Vineetha
    Al Amoodi, Abdulla
    Abdalla, Sami Fatehi
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (09)
  • [49] Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease
    Pérez-Severiano, F
    Ríos, C
    Segovia, J
    BRAIN RESEARCH, 2000, 862 (1-2) : 234 - 237
  • [50] Experimental therapeutics in transgenic mouse models of Huntington's disease
    Beal, MF
    Ferrante, RJ
    NATURE REVIEWS NEUROSCIENCE, 2004, 5 (05) : 373 - 384